Inhibition of GSK3α/β promotes increased pulmonary endothelial permeability to albumin by reactive oxygen/nitrogen species

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 6, 2013, Pages 685-692

  Neumann, Paul ^a   Alsaffar, Hiba ^a   Gertzberg, Nancy ^a   Johnson, Arnold ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

catenin; Endothelial permeability; Inflammation; Lung injury

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ACETOACETIC ACID; ALBUMIN; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITROGEN DERIVATIVE; REACTIVE OXYGEN METABOLITE; TIRON; TRICIRIBINE;

ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; LUNG ENDOTHELIUM; NONHUMAN; OXIDATION; PERMEABILITY; PRIORITY JOURNAL; RAT;

ENDOTHELIAL PERMEABILITY; INFLAMMATION; LUNG INJURY; Β-CATENIN;

ALBUMINS; ANIMALS; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; INDOLES; LUNG; MALEIMIDES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84888012395     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.06.001     Document Type: Article

References (36)

1. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. JCell Sci 2003, 116:1175-1186.
2. Bauer M., Willert K. Wnt signaling: the beta-cat(enin)'s meow. Genes Dev 2012, 26:105-109.
3. Gurrieri C., Piazza F., Gnoato M., Montini B., Biasutto L., Gattazzo C., et al. 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis. JPharmacol Exp Ther 2010, 332:785-794.
4. Hagen T., Di Daniel E., Culbert A.A., Reith A.D. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells. JBiol Chem 2002, 277:23330-23335.
5. Cheng J.Q., Lindsley C.W., Cheng G.Z., Yang H., Nicosia S.V. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 2005, 24:7482-7492.
6. Shiojima I., Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 2006, 20:3347-3365.
7. Kim M., Datta A., Brakeman P., Yu W., Mostov K.E. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3β in 3D epithelial morphogenesis. JCell Sci 2007, 120:2309-2317.
8. Kostyak J.C., Hunter J.C., Korzick D.H. Acute PKCdelta inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3beta. Cardiovasc Res 2006, 70:325-334.
9. Severson E.A., Kwon M., Hilgarth R.S., Parkos C.A., Nusrat A. Glycogen synthase kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem Biophys Res Commun 2010, 397:592-597.
10. Du Q., Park K.S., Guo Z., He P., Nagashima M., Shao L., et al. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling. Cancer Res 2006, 66:7024-7031.
11. Dugo L., Abdelrahman M., Murch O., Mazzon E., Cuzzocrea S., Thiemermann C. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock 2006, 25:485-491.
12. Bao Z., Lim S., Liao W., Lin Y., Thiemermann C., Leung B.P., et al. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med 2007, 176:431-438.
13. Cuzzocrea S., Crisafulli C., Mazzon E., Esposito E., Muia C., Abdelrahman M., et al. Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice. Br J Pharmacol 2006, 149:687-702.
14. Barton-Pai A., Feleder C., Johnson A. Tumor necrosis factor-alpha induces increased lung vascular permeability: a role for GSK3alpha/beta. Eur J Pharmacol 2011, 657:159-166.
15. Cuzzocrea S., Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., et al. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. JPharmacol Exp Ther 2006, 318:79-89.
16. Ferro T.J., Hocking D.C., Johnson A. Tumor necrosis factor-alpha alters pulmonary vasoreactivity via neutrophil-derived oxidants. Am J Physiol 1993, 265:L462-L471.
17. Gertzberg N., Gurnani T., Neumann P., Forbes A.-K., Jean-Louis N., Johnson A. Tumor necrosis factor-α causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in β-actin. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1219-L1229.
18. Ledenev A.N., Konstantinov A.A., Popova E., Ruuge E.K. Asimple assay of the superoxide generation rate with tiron as an EPR-visible radical scavenger. Biochem Int 1986, 13:391-396.
19. Phelps D.T., Ferro T.J., Higgins P.J., Shankar R., Parker D.M., Johnson A. TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995, 269:L551-L559.
20. Schreibelt G., Kooij G., Reijerkerk A., van Doorn R., Gringhuis S.I., van der Pol S., et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 2007, 21:3666-3676.
21. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996, 15:6541-6551.
22. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S.Y., et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006, 127:125-137.
23. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
24. Liu F., Schaphorst K.L., Verin A.D., Jacobs K., Birukova A., Day R.M., et al. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3beta. FASEB J 2002, 16:950-962.
25. Yang J., Duh E.J., Caldwell R.B., Behzadian M.A. Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression. Invest Ophthalmol Vis Sci 2010, 51:3273-3280.
26. Toker A., Newton A.C. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. JBiol Chem 2000, 275:8271-8274.
27. Wang Q.M., Fiol C.J., DePaoli-Roach A.A., Roach P.J. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. JBiol Chem 1994, 269:14566-14574.
28. Demarchi F., Bertoli C., Sandy P., Schneider C. Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. JBiol Chem 2003, 278:39583-39590.
29. Staal F.J.T., Burgering B.M.T., van de Wetering M., Clevers H.C. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells. Int Immunol 1999, 11:317-323.
30. Beurel E., Blivet-Van Eggelpoel M.J., Kornprobst M., Moritz S., Delelo R., Paye F., et al. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells. Biochem Pharmacol 2009, 77:54-65.
31. Kim J.S., Yeo S., Shin D.G., Bae Y.S., Lee J.J., Chin B.R., et al. Glycogen synthase kinase 3beta and beta-catenin pathway is involved in toll-like receptor 4-mediated NADPH oxidase 1 expression in macrophages. FEBS J 2010, 277:2830-2837.
32. Vines A., Cahoon S., Goldberg I., Saxena U., Pillarisetti S. Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression. JBiol Chem 2006, 281:16985-16990.
33. Gory S., Dalmon J., Prandini M.-H., Kortulewski T., de Launoit Y., Huber P. Requirement of a GT Box (Sp1 site) and two ets binding sites for vascular endothelial cadherin gene transcription. JBiol Chem 1998, 273:6750-6755.
34. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct notch target required for initiation of cardiac cushion cellularization. JCell Biol 2008, 182:315-325.
35. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008, 28:223-232.
36. Eto M., Kouroedov A., Cosentino F., Luscher T.F. Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-alpha. Circulation 2005, 112:1316-1322.